Compare FLY & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLY | MIR |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | 1409 | 3281 |
| Industry | Military/Government/Technical | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | N/A | N/A |
| Metric | FLY | MIR |
|---|---|---|
| Price | $39.93 | $18.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $38.88 | $27.25 |
| AVG Volume (30 Days) | ★ 5.5M | 3.4M |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $174.79 | $23.95 |
| Revenue Next Year | $66.73 | $7.32 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.00 | $16.43 |
| 52 Week High | $55.00 | $30.28 |
| Indicator | FLY | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 44.16 |
| Support Level | $18.95 | $16.98 |
| Resistance Level | $48.28 | $20.70 |
| Average True Range (ATR) | 3.79 | 0.96 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 89.20 | 49.75 |
Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.